Skip to main content
logo
MDNA Life Sciences Inc. (MDLS)
MDNA Life Sciences was planning to go public, but the IPO was withdrawn on Feb 21, 2025.
IPO Price Range
$5.00 - $6.00
Shares Offered
2,454,545
Deal Size
$13.50M

MDNA Life Sciences Balance Sheet

Millions USD. Fiscal year is Oct - Sep.

Assets

Year Ending
Sep '21 Sep '20
Cash & Equivalents
0.960.05
Cash & Cash Equivalents
0.960.05
Cash Growth
1801.44%-
Receivables
0.180.06
Inventory
-0.01
Other Current Assets
0.080.23
Total Current Assets
1.220.35
Property, Plant & Equipment
0.350.36
Goodwill and Intangibles
1.561.74
Other Long-Term Assets
0.060
Total Long-Term Assets
1.972.1
Total Assets
3.192.45

Liabilities

Year Ending
Sep '21 Sep '20
Accounts Payable
2.062.03
Deferred Revenue
0.710.47
Current Debt
15.460.71
Other Current Liabilities
1.360.78
Total Current Liabilities
19.594
Long-Term Debt
1.2313.48
Total Long-Term Liabilities
1.2313.48
Total Liabilities
20.8217.48

Shareholders' Equity

Year Ending
Sep '21 Sep '20
Retained Earnings
-45.35-41.56
Comprehensive Income
0.01-0.01
Shareholders' Equity
-17.62-15.03

Additional Metrics

Year Ending
Sep '21 Sep '20
Total Debt
16.6914.19
Debt Growth
17.60%-
Net Cash (Debt)
-15.73-14.14
Net Cash (Debt) Growth
--
Working Capital
-18.37-3.65